Turning a corner: Private market posts best month in yearsCore private market metrics suggest positive momentum is brewing and investor sentiment is improving
Turning a corner: Private market posts best month in years
Trading
Data
Solutions
Insights
About
Tango Therapeutics delivers the next generation of precision medicine to people with cancer that leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 8/17/2020 | Series B-1 | $51.18MM raised | $XXX.XX | $XXX.XX |
| 4/9/2020 | Series B | $60MM raised | $XXX.XX | $XXX.XX |
| 3/30/2017 | Series A | $55.7MM raised | $XXX.XX | $XXX.XX |
